chlorpromazine has been researched along with calcitriol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fenwick, JC; Flik, G; Smith, J; Smith, K | 1 |
| Hokari, S; Komoda, T; Koyama, I; Miyazaki, T; Oh-ie, K | 1 |
| Badea, I; Chitanda, JM; Michel, D; Singh, J; Verrall, RE | 1 |
1 review(s) available for chlorpromazine and calcitriol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for chlorpromazine and calcitriol
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of various vitamin D analogs on plasma calcium and phosphorus and intestinal calcium absorption in fed and unfed American eels, Anguilla rostrata.
Topics: 24,25-Dihydroxyvitamin D 3; Animals; Calcitriol; Calcium; Chlorpromazine; Cholecalciferol; Dehydrocholesterols; Dihydroxycholecalciferols; Eels; Ergocalciferols; Fasting; Food; Intestinal Absorption; Phosphorus | 1984 |
Altered bone turnover in chlorpromazine-challenged rats and its effect on 1alpha-hydroxyvitamin D3 administration in vivo.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Blotting, Western; Body Weight; Bone Marrow; Bone Remodeling; Calcitriol; Calcium; Chlorpromazine; Dopamine Antagonists; Drug Interactions; Interleukin-6; Male; Phosphates; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
Topics: Amino Acids; Animals; beta-Cyclodextrins; Biological Transport; Calcitriol; Caveolae; Cells, Cultured; Chlorpromazine; Clathrin; DNA; Endosomes; Gene Expression; Gene Transfer Techniques; Hydrogen-Ion Concentration; Interferon-gamma; Lipids; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Rabbits; Surface-Active Agents; Transfection | 2012 |